Featured Research

from universities, journals, and other organizations

Alternative Treatment Brings Hearing To Both Ears

Date:
August 4, 2007
Source:
Loyola University Medical Center
Summary:
Thomas Lynch, age 2, is now able to hear on both sides of his head with a new device and surgical procedure. Born with no ear canal on his left side, Tom had significant hearing impairment and went to Loyola University Medical Center, where Dr. Sam Marzo surgically implanted a bone-anchored cochlear stimulator that delivers sound to the inner ear by bone conduction.

Thomas Lynch, age 2, is now able to hear on both sides of his head with a device and surgical procedure pioneered by a surgeon-led team at Loyola University Medical Center.

Born with no ear canal on his left side, Tom had significant hearing impairment and went to Loyola University Medical Center, where Dr. Sam Marzo surgically implanted a bone-anchored cochlear stimulator that delivers sound to the inner ear by bone conduction. Marzo activated Tom’s device at Loyola’s Oakbrook Terrace Medical Center.

“It harnesses the ability of the skull bone to conduct sound vibrations,” said Marzo, associate professor of otolaryngology, Loyola University Chicago Stritch School of Medicine, Maywood, Ill. “It will enable Tom to perceive sounds on both sides of his head, which is critical for his speech development.”

Bone conduction is an alternative way to stimulate the cochlea if the regular sound route—via the ear canal—is interrupted or not available. The cochlea is the snail-shaped part of the inner ear that is responsible for hearing.

The device may be an alternative for people whose deafness cannot be helped by traditional hearing aids or cochlear implants.

The treatment is applicable for single-sided deafness, which affects some 60,000 people each year. The device can be snapped on and off—for showering and sleeping.

“People unable to hear as a result of chronic ear inflammation or drainage can benefit from this new therapy,” said Marzo, who also serves as program director of the Hearing and Balance Center at Loyola’s Oakbrook Terrace Medical Center, One South Summit Ave, Oakbrook Terrace, Ill. “The device will work for people who do not have a functioning ear canal.”

It has successfully treated sudden hearing loss, as well as hearing loss secondary to acoustic neuroma (tumor) and Meniere's disease (excessive fluid in the inner ear.)

Marzo noted that patients must have one working cochlea for the treatment to be effective.

To provide the therapy, a small titanium post is surgically implanted in the skull bone, one-half inch behind the ear. It takes three months for the implant to be integrated into the bone. A 1.5-inch x 1-inch sound processor, which snaps onto the post, transmits sound via bone conduction directly to the cochlea. The result is the sensation of hearing from both ears.

Hearing is an important safety issue, Marzo said. For example, walkers, joggers and bicyclists need to hear oncoming traffic. “Without being able to hear on both sides, it is difficult to perceive direction,” he said.

Marzo has a non-invasive test to determine if the bone-anchored hearing aid will be effective for a patient. To begin, the patient puts on what appears to be a set of headphones. One of the earpieces is placed on the mastoid bone behind the ear. This earpiece is a bone oscillator, the size of a U.S. quarter in radius that will send sound waves to the inner ear via bone conduction. Then, for the test, the patient blocks out any ear canal sound by putting a finger in each ear. The device is turned on. “If they are able to hear at this point, the procedure will work,” said Marzo.


Story Source:

The above story is based on materials provided by Loyola University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Medical Center. "Alternative Treatment Brings Hearing To Both Ears." ScienceDaily. ScienceDaily, 4 August 2007. <www.sciencedaily.com/releases/2007/08/070803151105.htm>.
Loyola University Medical Center. (2007, August 4). Alternative Treatment Brings Hearing To Both Ears. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/08/070803151105.htm
Loyola University Medical Center. "Alternative Treatment Brings Hearing To Both Ears." ScienceDaily. www.sciencedaily.com/releases/2007/08/070803151105.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins